Navigation Links
ImmunoVaccine Technologies Presents at OneMed Place Finance Forum
Date:1/9/2009

HALIFAX, NS, Jan. 9 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, announced today that it will present at the OneMedPlace Finance Forum on Tuesday, January 13, 2009 in San Francisco, CA. For more information visit www.onemedplace.com.

Dr. Randal Chase, president and CEO of ImmunoVaccine Technologies Inc., will speak at 8:45 am PST on the development of its superior vaccine delivery system, DepoVax(TM). DepoVax(TM) is being used to develop a single-dose rapid response pandemic influenza vaccine and a potent immunotherapeutic vaccine. The DepoVax(TM) platform has broad applicability with any antigen, including DNA-based antigens, and can also be used for SiRNA therapies.

About IVT

ImmunoVaccine Technologies Inc., winner of Canada's Top 10 Life Sciences Companies, is a private, clinical-stage, vaccine development company. Through its own biotech research, patented VacciMax(R) and DepoVax(TM) technologies, and collaborations with partners, IVT creates vaccines with the potential to help save and improve lives around the world.

In January 2008, IVT licensed its technology to Pfizer Animal health for two indications for infectious diseases in livestock, marking a pivotal step in achieving its vision of delivering breakthrough vaccines. www.immunovaccine.com.


'/>"/>
SOURCE ImmunoVaccine Technologies Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
2. ImmunoVaccine Technologies Congratulates Dr. Ramila Philip as One of PAs Best 50 Women in Business
3. ImmunoVaccine Technologies Patents DepoVax(TM) Vaccine Platform
4. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
5. ImmunoVaccine Technologies Inc. Nears Phase I Clinical Trials with Completion of Scientific Advisory Board
6. Volcano Announces Closing of Axsun Technologies Acquisition
7. GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.
8. ISTO Technologies to Present at OneMedPlace Emerging Company Finance Conference
9. BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
10. BioStorage Technologies Partners with Susan G. Komen for the Cure(R) Tissue Bank at the IU Simon Cancer Center in Breast Cancer Research Initiative
11. RainDance Technologies and Harvard University to Share in First Massachusetts Life Sciences Center Cooperative Research Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Burkina Faso (PRWEB) July 10, 2014 ... Faso, today have access to an additional family ... increase access to contraception at all levels of ... a lower-dose formulation of a widely used contraceptive—Pfizer’s ... system. , Burkina Faso is the first of ...
(Date:7/10/2014)... Terascala, the industry leader in ... a former vice president of product management for Flexera ... of marketing. Terascala’s software when combined with leading compute ... highest performance and most reliable solutions for processing big ... channel expansion and broaden its product portfolio. His leadership ...
(Date:7/10/2014)... EvoDerma ’s NOOME Anti-Aging Motion has been ... comes with a second treatment cup to help prevent and ... cup is thinner on the edges for a softer contact ... and uneven surfaces on the face, neck and décolleté. Choose ... on areas such as the cheeks and neck, or opt ...
(Date:7/10/2014)... July 10, 2014  Kainos Capital, a firm specializing ... announced that it has acquired the Slim-Fast brand from ... business. Terms of the transaction were not disclosed. ... replacement business that markets ready-to-drink shakes, powders, bars and ... and in the United Kingdom ...
Breaking Biology Technology:Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6Terascala Expands Executive Team 2Terascala Expands Executive Team 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Kainos Capital Acquires Slim-Fast From Unilever 2
... squarely in front of the nation again, and myriads of opinions ... opinions, we see they are driven by an almost equal number ... in this debate. , ,A recent article run ... a good example to use to examine one small part of ...
... Foundry has reported a GAAP loss of $1.9 million, ... fiscal 2007, but the company's quarterly revenues continue to rise. ... its Q2 net loss compares to a GAAP loss of ... of 2006. Included in the 2007 number is $395,000 in ...
... Wis. - PunchStock , a Madison-based stock image distributor, ... to a report in pdn online . , ... is part of a business strategy for Getty Images to operate ... ,PunchStock employs 60 people and has offices in Madison, New York, ...
Cached Biology Technology:Misconceptions dominate the immigration debate 2Misconceptions dominate the immigration debate 3Misconceptions dominate the immigration debate 4Misconceptions dominate the immigration debate 5
(Date:7/10/2014)...  Aware, Inc. (NASDAQ: AWRE ), a ... on June 26, 2014 that its Board of Directors ... share, or approximately $40 million in total.  The Board ... a payment date of July 24, 2014.  The Company ... an ex-dividend date for this special cash dividend.  An ...
(Date:7/10/2014)... 2, 2014  Unisys Corporation,s (NYSE: UIS ) ... N.V., today announced that it has been selected by the ... a new Basic Provision Biometrics solution for penitentiaries across ... the contract with a solution based on its open standards-based ... of the contract is up to seven years, with the ...
(Date:7/10/2014)... , July 2, 2014 NXT-ID, Inc., (OTCQB: NXTD) a biometric ... CEO Mr. Gino Pereira was interviewed on July ... Tampa Florida . Mr. Pereira discusses the ... Cedric Harris and how the Wocket™ aims to replace ... Cedric Harris tells Gino he has ...
Breaking Biology News(10 mins):NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 2Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 4
... McCarthy has won a $150,000 scholarship from the General ... the University of California, Berkeley. Mr McCarthy, who ... division, said he was looking forward to starting his ... for my PhD will help biologists to develop treatments ...
... the first time, scientists have created functioning human intestinal ... In a study posted online Dec. 12 by ... say their findings will open the door to unprecedented ... process is also a significant step toward generating intestinal ...
... Do not delay treatment of breast cancer just because ... med, of the German Breast Group. This suggestion is ... options on the infant. Loibl presented this data at the ... 8-12, 2010. "At the time we started the study ...
Cached Biology News:Statistician wins $150K scholarship to interpret biomedical data 2Stem cells turned into complex, functioning intestinal tissue in lab 2Stem cells turned into complex, functioning intestinal tissue in lab 3Unique needs and outcomes of pregnant women with breast cancer identified 2
... Vesicular Monoamine Transporter 2 (VMAT2). An ... detected a major band at ~55 kDa ... VMAT2 and not in wild type cells ... lower molecular weight, were also detected and ...
Immunogen for A300-655A was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 5 of the C-terminal repeat YSPTSPS....
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
... This CLS number ... number, created to easily ... If showing no availability ... the old Sigma-Aldrich number ...
Biology Products: